ZA857830B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA857830B
ZA857830B ZA857830A ZA857830A ZA857830B ZA 857830 B ZA857830 B ZA 857830B ZA 857830 A ZA857830 A ZA 857830A ZA 857830 A ZA857830 A ZA 857830A ZA 857830 B ZA857830 B ZA 857830B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ZA857830A
Other languages
English (en)
Inventor
Keith Sugden
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of ZA857830B publication Critical patent/ZA857830B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA857830A 1984-10-16 1985-10-11 Pharmaceutical compositions ZA857830B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848426152A GB8426152D0 (en) 1984-10-16 1984-10-16 Medicinal compositions

Publications (1)

Publication Number Publication Date
ZA857830B true ZA857830B (en) 1986-05-28

Family

ID=10568269

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA857830A ZA857830B (en) 1984-10-16 1985-10-11 Pharmaceutical compositions

Country Status (13)

Country Link
US (1) US4717723A (sv)
EP (1) EP0180364B1 (sv)
JP (1) JPH0645545B2 (sv)
AU (1) AU577161B2 (sv)
CA (1) CA1251735A (sv)
DE (1) DE3576276D1 (sv)
DK (1) DK165619C (sv)
GB (2) GB8426152D0 (sv)
GR (1) GR852481B (sv)
IE (1) IE58529B1 (sv)
NZ (1) NZ213698A (sv)
PT (1) PT81311B (sv)
ZA (1) ZA857830B (sv)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
GB8608818D0 (en) * 1986-04-11 1986-05-14 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5112616A (en) * 1988-11-30 1992-05-12 Schering Corporation Fast dissolving buccal tablet
US5002759A (en) * 1989-07-25 1991-03-26 Colgate-Palmolive Company Oligosaccharide inhibition of Streptococcus pyogenes adhesion
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
GB9508463D0 (en) * 1995-04-26 1995-06-14 Link Pharmaceuticals Limited Anti-emetic pharmaceutical compositions
AU2068797A (en) * 1996-01-29 1997-08-20 Edward Mendell Co. Inc. Sustained release excipient
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US6368625B1 (en) 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
US6270790B1 (en) * 1998-08-18 2001-08-07 Mxneil-Ppc, Inc. Soft, convex shaped chewable tablets having reduced friability
EP1118333A1 (en) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions with enhanced oral bioavailability
US20050142197A1 (en) * 2003-12-31 2005-06-30 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
US7862833B2 (en) * 2003-12-31 2011-01-04 Cima Labs, Inc. Effervescent oral opiate dosage forms and methods of administering opiates
WO2005065317A2 (en) * 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
DE102004003572A1 (de) * 2004-01-23 2005-08-18 Bavarian Nordic A/S Monoparamunitätsinducer basierend auf attenuierten Myxomaviren des Kaninchens
DE102005033943A1 (de) * 2005-07-20 2007-02-22 Hexal Ag Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum
GB2433887A (en) * 2006-01-04 2007-07-11 Reckitt Benckiser Healthcare Pack for phenothiazine derivatives
EP2320753B1 (en) * 2008-09-05 2011-12-21 Unilever N.V. Beverages comprising potassium
EP2437730A4 (en) * 2009-05-20 2014-02-26 Lingual Consegna Pty Ltd ORAL AND / OR SUBLINGUAL THERAPEUTIC FORMULATION

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2407486A (en) * 1941-11-21 1946-09-10 Du Pont Veterinary compositions
US3218232A (en) * 1962-11-09 1965-11-16 American Home Prod Method for relieving depression and composition therefor
US3557016A (en) * 1965-10-22 1971-01-19 Kelco Co Heat reversible gel and method for preparing same
US3700451A (en) * 1970-04-06 1972-10-24 Itek Corp Gelable and gelled compositions
US3944427A (en) * 1970-04-06 1976-03-16 Itek Corporation Gelable and gelled compositions
US4038206A (en) * 1976-01-15 1977-07-26 General Mills Chemicals, Inc. Hydroxyalkyl locust bean/xanthomonas hydrophilic colloid blends
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4425337A (en) * 1981-12-30 1984-01-10 Merck & Co., Inc. Adjuvants for rectal delivery of drug
US4559326A (en) * 1985-01-31 1985-12-17 Pfizer Inc. Antiinflammatory compositions and methods

Also Published As

Publication number Publication date
DK470685D0 (da) 1985-10-15
US4717723A (en) 1988-01-05
GB2165451B (en) 1988-07-06
AU4873385A (en) 1986-04-24
IE58529B1 (en) 1993-10-06
PT81311B (pt) 1987-11-30
CA1251735A (en) 1989-03-28
DK165619C (da) 1993-06-01
JPS61112019A (ja) 1986-05-30
GB8525175D0 (en) 1985-11-13
DK470685A (da) 1986-04-17
JPH0645545B2 (ja) 1994-06-15
DK165619B (da) 1992-12-28
NZ213698A (en) 1988-01-08
EP0180364B1 (en) 1990-03-07
PT81311A (en) 1985-11-01
GB8426152D0 (en) 1984-11-21
EP0180364A2 (en) 1986-05-07
GR852481B (sv) 1986-02-14
IE852525L (en) 1986-04-16
AU577161B2 (en) 1988-09-15
EP0180364A3 (en) 1987-08-19
GB2165451A (en) 1986-04-16
DE3576276D1 (de) 1990-04-12

Similar Documents

Publication Publication Date Title
GB8508452D0 (en) Pharmaceutical compositions
GB8403359D0 (en) Pharmaceutical compositions
GB8525709D0 (en) Pharmaceutical compositions
GB8413191D0 (en) Pharmaceutical composition
GB2165451B (en) Pharmaceutical compositions
ZA852831B (en) Pharmaceutical compositions
ZA852830B (en) Pharmaceutical compositions
GB8403360D0 (en) Pharmaceutical compositions
GB8503513D0 (en) Pharmaceutical compositions
GB8409961D0 (en) Pharmaceutical compositions
GB2153676B (en) Pharmaceutical composition
GB8524054D0 (en) Pharmaceutical compositions
CY1980A (en) Pharmaceutical compositions
GB8427877D0 (en) Pharmaceutical compositions
GB8426151D0 (en) Pharmaceutical compositions
GB8424957D0 (en) Pharmaceutical compositions
IE69569L (en) Pharmaceutical compositions
IE842522L (en) Pharmaceutical compositions
ZA84895B (en) Pharmaceutical compositions
GB8419244D0 (en) Pharmaceutical compositions
GB8416437D0 (en) Pharmaceutical compositions
GB8411116D0 (en) Pharmaceutical compositions
GB8431899D0 (en) Pharmaceutical compositions
GB8427486D0 (en) Pharmaceutical compositions
GB8426375D0 (en) Pharmaceutical compositions